Cell‐free concentrated ascites reinfusion therapy enables removal of extracellular vesicles and circulating immune complexes in ascites
The CART process with AHF-MO effectively removes EVs and CICs, reducing physiological activity and demonstrating its safety in ascites treatment.
Authors
- Akira Uchiyama (ORCID: https://orcid.org/0000-0003-3814-2760)
- Goh Murayama (ORCID: https://orcid.org/0000-0001-7539-8875)
- Yasuhisa Terao (ORCID: https://orcid.org/0000-0002-9126-3361)
- Atsuo Itakura (ORCID: https://orcid.org/0000-0002-4554-164X)
- Kenichi Ikejima (ORCID: https://orcid.org/0000-0002-2657-0840)
- Makio Kusaoi (ORCID: https://orcid.org/0000-0003-0064-4765)
- Takumi Saito (ORCID: https://orcid.org/0000-0002-6281-8620)
- Tomoko Miyashita (ORCID: https://orcid.org/0000-0003-1870-5781)
- Naoto Tamura (ORCID: https://orcid.org/0000-0003-1729-2954)
- Masanori Nojima (ORCID: https://orcid.org/0000-0002-8788-2522)
- Takashi Hirayama (ORCID: https://orcid.org/0000-0001-5993-6688)
- Moeko Inoue
- Ken Yamaji (ORCID: https://orcid.org/0000-0002-0565-1828)
- Yu Yamaji
- Y. Hagiwara
- Taiga Kuga
- Takuya Urita
Institutions
- Juntendo University (JP)
- Juntendo University Hospital (JP)
Publication Details
- Journal
- Therapeutic Apheresis and Dialysis
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1111/1744-9987.70022
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00